| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 07/08/2008 | CA2438596C Tetrahydro-pyrazino (1,2-a) indoles for the treatment of central nervous disorders |
| 07/08/2008 | CA2427985C Cartridges useful in cleaning dialysis solutions |
| 07/08/2008 | CA2136848C Pharmaceutically acceptable fixed-dried human blood platelets |
| 07/03/2008 | WO2008080009A2 Neuroprotection by blood flow stabilization |
| 07/03/2008 | WO2008079836A2 Macrocyclic factor viia inhibitors useful as anticoagulants |
| 07/03/2008 | WO2008079759A1 Bicyclic lactam factor viia inhibitors useful as anticoagulants |
| 07/03/2008 | WO2008078453A1 Platelet production promoting factor and use thereof |
| 07/03/2008 | WO2008077529A1 Synergistic therapeutic use of prothrombin complex concentrates with fviii concentrates |
| 07/03/2008 | WO2008055092A3 Use of enoxaparin sodium for treating patients with acute ischemic stroke |
| 07/03/2008 | WO2008054594A3 Method for controlling angiogenesis in animals |
| 07/03/2008 | WO2008052671A3 Combination therapy of substituted oxazolidinones |
| 07/03/2008 | WO2008043533A3 Acyl aminoimidazoles and acyl aminothiazoles |
| 07/03/2008 | WO2008039406A3 Rapidly disintegrating lyophilized oral formulations of a thrombin receptor antagonist |
| 07/03/2008 | WO2007139939A3 Methods and compositions using immunomodulatory compounds in combination therapy |
| 07/03/2008 | WO2007136653A3 Use of a rar antagonist or inverse agonist for the treatment of chemotherapy and/or radiation therapy side effects |
| 07/03/2008 | WO2007054783A3 Compositions and methods for treating thrombocytopenia |
| 07/03/2008 | US20080161413 Agent for increasing adiponectin in blood |
| 07/03/2008 | US20080161399 Agent for reduction of oxidized albumin level |
| 07/03/2008 | US20080161360 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes |
| 07/03/2008 | US20080161243 Chimeric B-type natriuretic peptide (BNP) polypeptide for use in treatment and prevention of cardiovascular disorders |
| 07/03/2008 | US20080161240 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 07/03/2008 | US20080160074 three-dimensional synthetic and semi-synthetic compositions having biological activity, such as liposomes, beads or similar particles; anti-inflammatory, organ protective and immune regulatory effects |
| 07/03/2008 | US20080160033 Novel Screening Method |
| 07/03/2008 | US20080160022 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules |
| 07/03/2008 | US20080160005 Interleukin-6 suppressive agent |
| 07/03/2008 | CA2673921A1 Substituted isoquinolines and their use as rho-kinase inhibitors |
| 07/03/2008 | CA2673598A1 Macrocyclic factor viia inhibitors useful as anticoagulants |
| 07/03/2008 | CA2673446A1 Synergistic therapeutic use of prothrombin complex concentrates with fviii concentrates |
| 07/02/2008 | EP1939203A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta isoform |
| 07/02/2008 | EP1938813A1 Agent for reduction of oxidized albumin level |
| 07/02/2008 | EP1937673A1 Imidazole derivatives as inhibitors of tafia |
| 07/02/2008 | EP1937271A1 Microangiopathy treatment and prevention |
| 07/02/2008 | EP1937234A1 Use of choline to prevent thrombosis associated with total parenteral nutrition |
| 07/02/2008 | EP1633745B1 Aroyl semicarbazide derivatives against thromboembolic diseases |
| 07/02/2008 | EP1501808B1 Tachykinin receptor antagonists |
| 07/02/2008 | EP1474425B9 Deazapurines and uses thereof |
| 07/02/2008 | EP1339749B1 Methods for producing improved dextran-hemoglobin conjugates |
| 07/02/2008 | EP1115720B1 Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 07/02/2008 | CN101210261A Method for preparing sipunculid polypeptide and application thereof |
| 07/02/2008 | CN101210239A Double-functional molecule for dissolving thrombus and inhibiting blood platelet aggregate and use thereof |
| 07/02/2008 | CN101209354A Medical blood-stopping healing agent for wound-surface and using thereof |
| 07/02/2008 | CN101209347A Pharmaceutical compositions of fibrinolytic agent |
| 07/02/2008 | CN101209319A Compound Chinese medicinal granule with heat-clearing and detoxication, damp-clearing and diuresis-promoting efficacy |
| 07/02/2008 | CN101209312A Digitalis extract and preparation thereof |
| 07/02/2008 | CN101209296A Chinese medicinal granule with worm-expelling liver-caring, hemostasis and dysentery-stopping efficacy |
| 07/02/2008 | CN101209260A Application of sulfated polysaccharides in preparing medicament with anticoagulant active |
| 07/02/2008 | CN101209102A Functional food for improving nutritional anemia |
| 07/02/2008 | CN101209075A Health care tea for female |
| 07/02/2008 | CN100398148C Nutrient and healthy capsule of active ass hide |
| 07/01/2008 | US7393859 Amide substituted imidazoquinolines |
| 07/01/2008 | US7393841 for improved microcirculation, cryo-conservation of blood components such as erythrocytes of granulocytes, and as sedimentation aid in cell separation in connection with leucapheresis |
| 07/01/2008 | US7393840 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 07/01/2008 | US7393838 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 06/26/2008 | WO2008075862A1 A method for preparing materials having antithrombotic activity from muskrat musk and materials obtained from the method |
| 06/26/2008 | WO2008075796A1 Agent for promoting recovery from blood cell depletion |
| 06/26/2008 | WO2008075621A1 Antacid |
| 06/26/2008 | WO2008074676A1 Pyrazolo [3, 4 -d] pyrimidine p38 map kinase inhibitors |
| 06/26/2008 | WO2008049881A3 Polypeptides and pharmaceutical compositions comprising the same for the prevention and treatment of complications associated with infectious diseases |
| 06/26/2008 | WO2008009639A3 New indications for direct thrombin inhibitors |
| 06/26/2008 | US20080153921 Amphipathic, lipophilic anti-oxidants, made into potent abzyme inhibitors by increasing solubility in aqueous solvents with lactoproteins; test solublized carotenoids, polyphenols, flavonoids, isoflavones, curcuminoids, ceramides to identify, obtain a composition which inhibits lipid oxidising abzymes |
| 06/26/2008 | US20080153899 Fatty amine drug conjugates |
| 06/26/2008 | US20080153876 Administering compound such as N-(5-chloro-pyridin-2-yl)-2-(4-cyano-benzoyl-amino)-5-methoxy-benzamide Hydrochloride for inhibiting coagulation |
| 06/26/2008 | US20080153849 Aqueous solution of calcium folinate and hydrochloric acid or acetic acid are added to stirred water; filtration, centrifuging; washing solid with cold water and solvent; drying under low pressure; concentrated, stable injection or infusion solutions; rescue agent for high doses of methotrexate |
| 06/26/2008 | US20080153769 A nucleic acid ligand whose sequence optionally includes a 2'-O-methyl modification and/or a 2'-O-fluoro modification, useful for inhibiting coagulation in a host undergoing a therapeutic regime such as surgery or coronary artery bypass |
| 06/26/2008 | US20080153751 Albumin Fusion Proteins |
| 06/26/2008 | US20080152656 Using kallikren specific inhibitor as therapeutic tool in treating cardiocascular disorders; treating soft tissue and bone trauma; tissue repair |
| 06/26/2008 | US20080152651 Beta-like glycoprotein hormone polypeptide specific immunoglobulin for treatment of autoimmune, inflammatory, (such as rheumatoid arthritis, psoriasis, multiple sclerosis, toxic shock, bone marrow and organ transplantation disorders |
| 06/26/2008 | CA2672758A1 Activin-actrii antagonists and uses for increasing red blood cell levels |
| 06/26/2008 | CA2672719A1 Pyrazolo [3, 4 -d] pyrimidine p38 map kinase inhibitors |
| 06/26/2008 | CA2672270A1 Treatments of therapy resistant diseases and drug combinations for treating the same |
| 06/25/2008 | EP1935874A1 S1p3 receptor antagonist |
| 06/25/2008 | EP1935429A1 Synergistic therapeutic use of prothrombin complex concentrates with FVIII concentrates |
| 06/25/2008 | EP1935427A2 Methods for treating rheumatoid diseases using a soluble CTLA4 mutant molecule |
| 06/25/2008 | EP1934262A1 Antibodies to complementary peptides of thrombin or portions thereof |
| 06/25/2008 | EP1934208A1 Novel polymorphous form and the amorphous form of 5-chloro-n-({ (5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide |
| 06/25/2008 | EP1933851A1 Vitamin b-12 compositions |
| 06/25/2008 | EP1933831A2 Modulators of atp-binding cassette transporters |
| 06/25/2008 | EP1603572A4 Lactam-containing cyclic diamines and derivatives as factor xa inhibitors |
| 06/25/2008 | EP1286962B1 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds |
| 06/25/2008 | EP1261320B1 Micellar pharmaceutical compositions for buccal and pulmonary application |
| 06/25/2008 | EP0805859B2 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. |
| 06/25/2008 | CN101208334A Novel cyclic amines |
| 06/25/2008 | CN101205205A Alanine derivatives |
| 06/25/2008 | CN101204572A Preoral Chinese traditional medicine for spleen-stomach deficiency-cold hematemesis |
| 06/25/2008 | CN101204557A Peroral Chinese traditional medicine decoction for leukocytopenia |
| 06/25/2008 | CN101204547A Peroral Chinese traditional medicine for yangcollaterals injury inducing emptysis |
| 06/25/2008 | CN101204544A Peroral Chinese traditional medicine for kidney-inducing emptysis |
| 06/25/2008 | CN101204529A Medicine for wound-curing and scar-dispeling |
| 06/25/2008 | CN101204500A Preparation method and composition and Chinese traditional medicine preparation for preventing and curing hyperuricaemia |
| 06/25/2008 | CN101204497A Peroral Chinese traditional medicine for aplastic anemia |
| 06/25/2008 | CN101204434A Quality standard for thrombus dispelling pill and test method thereof |
| 06/25/2008 | CN101204402A Vacuum freezing and drying technology for leech |
| 06/25/2008 | CN101204225A Medical food with the function of enriching blood and moistening lung |
| 06/25/2008 | CN100396695C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 06/25/2008 | CN100396678C Synthesis and uses of indole analogs of 1-benzyl-3-(5'-hydroxymethy 1-2' -furyl) indazole |
| 06/25/2008 | CN100396330C Composition and method for repairing nerve damage and enhancing functional recovery of nerve |
| 06/25/2008 | CN100396289C Scutellarin injection preparation and its preparing method |
| 06/25/2008 | CN100396288C Use of pennogenin in preparing medicines for enhance of hemopoietic function |
| 06/24/2008 | US7390905 Tachykinin receptor antagonists for use treating e.g. emesis, depression, urinary disorder |
| 06/24/2008 | US7390783 Charged phospholipid compositions and methods for their use |